Join
Live feed
·
PRReleasevia Quantisnow
Creative Medical Technology Holdings Inc. logo

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

ByQuantisnow·Wall Street's wire, on your screen.
CELZ· Creative Medical Technology Holdings Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELZ (Creative Medical Technology Holdings Inc.) and more on Quantisnow.